1. Home
  2. BAC vs MRK Comparison

BAC vs MRK Comparison

Compare BAC & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of America Corporation

BAC

Bank of America Corporation

HOLD

Current Price

$50.00

Market Cap

364.1B

Sector

Finance

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$113.76

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAC
MRK
Founded
1784
2000
Country
United States
United States
Employees
213000
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
364.1B
268.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BAC
MRK
Price
$50.00
$113.76
Analyst Decision
Buy
Buy
Analyst Count
20
17
Target Price
$60.34
$125.59
AVG Volume (30 Days)
29.2M
7.6M
Earning Date
04-15-2026
04-30-2026
Dividend Yield
2.12%
3.06%
EPS Growth
N/A
8.01
EPS
N/A
N/A
Revenue
N/A
$65,011,000,000.00
Revenue This Year
$13.11
$3.61
Revenue Next Year
$5.80
$5.41
P/E Ratio
$14.01
N/A
Revenue Growth
N/A
1.31
52 Week Low
$42.35
$75.40
52 Week High
$57.55
$125.14

Technical Indicators

Market Signals
Indicator
BAC
MRK
Relative Strength Index (RSI) 38.93 49.47
Support Level $48.88 $113.27
Resistance Level $53.48 $124.57
Average True Range (ATR) 1.12 2.52
MACD -0.46 0.25
Stochastic Oscillator 2.75 88.47

Price Performance

Historical Comparison
BAC
MRK

About BAC Bank of America Corporation

Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: